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Abstract 
 
 Background and Objectives:  Atrial fibrillation is one of the  most common atrial arrhythmia , it may be 
associated with alote of structural and  functional cardiac causes . The Aim of this study was to evaluate a 
possible causal relationship between ASA ( atrial septal aneurysm ) and the occurrence of paroxysmal AF in 
young and middle age patients , and reporting of  some other structural and pathological abnormality diagnosed 
by standard transthoracic echocardiography. 
 
Design and Methods: This study was involved  young and middle age groups (20-55 years), itincluded 339 
patients with new paroxysmal atrial fibrillation , but 37 of them was excluded from the study, (male 250 and 
female 52) with additional 300 control group. All patients were examined By standard transthoracic 
echocardiographic  protochol that involve two dimension ( 2D) , M-Mood and dopplar , looking for possible 
cardiac structural causes for the  new onset  paroxysmal atrial fibrillation and special attention was made to the 
inter atrial septum. 
 
The Results: The paroxysmal atrial fibrillation is more with 41-55 years age group that represents 65.56% of 
patients , while the age group  20-40 years which give 34.44%. The paroxysmal atrial fibrillation is  more in 
male group (82.78%), than  female group ( 17.22%) . The paroxysmal atrial fibrillation patients show many 
associated heart abnormalities (acquired and congenital diseases) by echocardiographic results, and specifically, 
the ASA is 17.21% in AF patients. The highest percentage of  ASA are 21.2% in the age group 41-55 years old, 
and 18.4% in male group, with significant relationship between them(P value < 0.05, odds ratio is 12.3, chi-
square is 42.64 , 95% confidence interval 4.8-31.19).  
 
Conclusion: Echocardiography has a significant  role  in the  diagnosis of  causes of AF. There is a strong 
association of ASA and the onset of new paroxysmal AF, More for those patients older than 41 years old , more 
in male than female. 
 
Keywords: new/paroxysmal atrial fibrillation (AF), transthoracic echocardiographic machine (TTE), atrial 
septal aneurysm (ASA). 
 
. 
 
Journal of University of Babylon, Pure and Applied Sciences,Vol.(26), No.(5): 2018 
472 
 
(P <0.05 
 
 
Introduction 
 
Atrial septal aneurysm (ASA) is a secular deformity at  the inter atrial septum at area of fossa 
ovali,  that move to left or right atrium or both by at least 10mm with a distance  across their base of 
about 15 mm,  they can be associated  with ASD, PFO and MVP and cand be a possible cardiac cause 
of emboli and arrhythmia[1]. Atrial fibrillation (AF) is a supraventricular arrhythmia that refers to 
irregular mechanical and electricalatrial activity. More Thus, the electrical activity of atria gives  
fluctuations that called fibrillatory (f) waves with atrial rate about 300 beats/minute,atrial fibrillation 
is a common arrhythmia and its prevalence in general population  is about  1.5%-2%[2] 
 
 The occurrence of atrial fibrillation is believed  to happen from either focal ectopic triggered or 
from reentry pathways [3]. More than 80% of patients with  structural heart diseases produce atrial 
tissue changes (inflammation and fibrosis)which is responsible for sustaining the atrial fibrillation.The 
risk of occurring atrial fibrillation is 23%-26% for females and males respectively. Age is a 
dependable risk factor for the atrial fibrillation and when the age is more than 60 years old ,the age 
risk is double with each life decade. The prevalence of atrial fibrillation is more in males than 
females. New-onset atrial fibrillation shows a high risk of cardiovascular diseases and death[4].  
 
The last data in the European Union by age beyond 55 years old and between 2010-2060 is to 
become about 17.9 million [5]. The common symptom of atrial fibrillation is fatigue[6] (while the 
other symptoms are palpitation, chest pain, dyspnea, lightheadedness,and asymptomatic that occurs  
specially in elderyage group [7].  
 
Atrial fibrillation can occur without any diseases which called idiopathic (lone) atrial 
fibrillation(Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns H, et al. International 
consensus on nomenclature and classification of atrial fibrillation. Europace 2003 
[8] or due to other diseases for examples cardiovascular disease, diabetes mellitus, hypertension , and 
obesity (The National Collaborating Centre for Chronic Conditions) [9] 
 
In addition, there are other associated diseases with atrial fibrillation such as coronary heart 
disease, valvular heart disease, alcohol, caffeine, heart failure[10], and family history[11].Also, 
secondary atrial fibrillation can occur in situations that include pericarditis, myocarditis, 
hyperthyroidism, pulmonary embolism, and  pneumonia [10]. 
 
       Atrial fibrillation is classified by United State (AHA/ACC/HRS 2014), into two types, 
the first diagnosed atrial fibrillation and recurrent atrial fibrillation. Recurrent atrial 
fibrillation includes, the paroxysmal if it is finished spontaneously and the atrial fibrillation,  
which  has treated with cardioversion within 7 days), persistent atrial fibrillation ( it is more 
than 7 days) , long-lasting persistent (it is more than 12 months and for targeting rhythm 
control system), permanent atrial fibrillation (it is more than 1 years and more efforts to 
restore and/or keep sinus rhythm excluded[12]. 
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      Progression of atrial fibrillation may occur and it is usually from paroxysmal type to a permanent 
one (specially elderly age group), but the progression expectations is not well understanding and it 
depend highly on presence of seriousness ofstructural heart diseases. The most expectations factors 
for the progression are the age, diabetes mellitus, and the heart failure[13].  
 
    Laboratory investigations include complete blood count with serum electrolyte, coagulation status, 
assessing the functions of kidney and liver, brain natriuretic peptide with troponin I , thyroid  function 
test, and D-dimer test[14]. 
 
 Finally, atrial fibrillation is diagnosed simply by irregular RR interval with f waves in 
electrocardiographic technique. [2]. 
 
    Complications of atrial fibrillation are stroke (5 folds), heart failure (3 folds), dementia and 
mortality (double folds) [6]. 
 
     The goal of atrial fibrillation treatment is decrease symptoms, prevent complications, and this is 
done by holding the rate of ventricles, underlying abnormalities management, and thromboembolic  
prevention[9] (The National Collaborating Centre for Chronic Conditions). 
 
     Echocardiography have a very important role and specially if the patient is hemodynamically 
unstable[15], Transthoracic echocardiography (TTE) is an ultrasound instrument, non-invasive  
system,  portable, low price, and it has an actual-time imaging [9] (The National Collaborating Centre 
for Chronic Conditions). 
 
 Transthoracic echocardiography  gives full information about the heart and vessels structure and 
function, and it has good effect  on diagnosis and  management of patients. However, 2D TTE  has 
perfect measurement for size of heart chambers, ventriculars function , heart wall thickness, structure 
of heart valves and great vessel diameters. Pulsewave, continuous wave, and color flow Doppler 
echocardiography measures speeds of blood flow, estimate pressure inside the heart and 
hemodynamics, and it can identify and measure the degree of valve stenosis, regurgitation, and other 
flow abnormality . 
 
       Transthoracic echocardiography has many technologies and it includes two parts (1) simple 
modes that involve the M-mode, 2D/cross-sectional and Doppler modes (color flow mapping, 
continuous waves, and pulsed wave), (2) Complex or invasive modes of TTE include stress/exercise 
echocardiography, three-dimensional echocardiography, contrast echocardiography, and 
intraoperative echocardiography[16]. 
 
Methods 
 
This is a case control study,  preformed in Babyllon  / MarjanTeaching hospital, in the period that 
extended from February/2016 to February /2017. The clinical data of patients include age, sex, 
Residence, past medical, family, social history were taken, all patients with new AF paroxysm or 1
st
 
diagnosed AF are included, exclusion criteria that include any patient dose not welling to participate 
on this study and patients with Past history of IHD, uncontrolled Hypertension, active alcoholism, 
thyrotoxic patient, or any patient with clear cause of his AF attack other than structural heart disease 
apart from ischemia. A written informed concept was given to all patients enrolled in this study. 
 
     339 patients were  enrolled in this study, 302 of them are included  in the study, and 37 of them are 
excluded from the study (an overt cause is present like hyperthyroidism , pneumonia, severe 
hypertension, alcoholism). Age of patients presentation are ranging between  20-55 years old, with 
250 are male, and 52 are female. All patients referred from CCU with first diagnosis of AF and 
underwent transthoracic echocardiographic examination as a routine examination to detect structural 
heart disease that might be the cause for AF and special attention was paid to  ASA. 
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     Transthoracic echocardiography with two-dimension (2D) and 2D guided M-mode  are done 
according to standard method [17].  A Vivid E9  ultrasound machine used with 5 MSc (matrix)  probe 
and 3D probe  with full Doppler capability in addition to 3D and Multiplan mode views . 
 
    The Inter atrial septum was visualized carefully by apical 4 chamber view with zoom option to 
detect the abnormal motion near septum ovali , the site for ASA, which appear as a secular deformity 
move to left of right atrium or both . Other data like ejection fraction EF%, LA volume index, valves 
structure and function, myocardium , pericardium and Ascending aorta , Right side study, pulmonary 
artery pressure all were measured . 
SPSS 22 computer program was used for full statistical analysis. Results were expressed as chi-sequar 
and frequency expressed as a percentage and Statistical is regarded as significant when a p value < 
0.05. 
 
Results 
 
Total patients with paroxysmal atrial fibrillation was 339 which are divided into 302 (included 
patients) and 37 (excluded patients). While,  300 persons as control group . 
The minimum age in patients and control group are 20  while The maximum age in both patients 
and control group are 55  as in table (1). 
 
Table (1): Age groups distribution in patients with paroxysmal atrial fibrillation and control groups. 
 
 Figure (1), show the paroxysmal atrial fibrillation is more commor in patients age group (41-55)years that 
represents 65.56% of patients, in compare to patients with age group ( 20-40)years which give 34.44% . 
 
 
 
Figure (1): Patients age percentage in association with paroxysmal atrial 
fibrillation. 
 
      The paroxysmal atrial fibrillation is more common in male group  that represents 
83.3%  and 82.78%  in control and patients group, respectively, while the paroxysmal 
atrial fibrillation is less frequent in female group  that represents 16.7%  and 17.22%  in 
control and patients group respectively as in table (2). 
 
Table (2): Distribution of sex group in patients with paroxysmal atrial fibrillation and 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
20-40 years41-55 years
ةلسلس1  34.44%65.56%
patients group (%) control group (%)  Age group/years 
104 (34.44%) 100 (33.3%) 20-40 
198 (65.56%) 200 (66.7%) 41-55 
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control group. 
 
patients   group (%) control group (%) Sex group 
250 (82.78%) 250 (83.3%) Male 
52 (17.22%) 50 (16.7%) Female 
 
 
Figure (2): Distribution of paroxysmal AF according to sex  
 
Table (3):  Distribution of the Patients  with  paroxysmal atrial fibrillation   that have  
an atrial septal aneurysm according to age and sex. 
Variables 
 
 
atrial septal aneurysm 
findings in Patients 
with atrial fibrillation 
Total Patients with atrial 
fibrillation 
P value 
Number (%) Number 
*P value < 0.0001 
 
Age Group (years) 
20-40 
 
41-55 
 
10 (9.6%) 
 
42 (21.2%) 
104 
 
198 
 
Sex group 
Male 
 
Female 
 
 
46 (18.4%) 
 
6 (11.5%) 
250 
 
52 
*P value < 0.0001 
Odds ratio 12.5 
  
95% confidence 
interval 
Upper limits- 31.19 
Lower limits- 4.8 
Chi-square 42.64 
*P value ≤0.05 is significant 
 
Male 
83% 
Female 
17% 
Journal of University of Babylon, Pure and Applied Sciences,Vol.(26), No.(5): 2018 
472 
 
In table (4), The patients with paroxysmal atrial fibrillation shows many associated heart 
abnormalities (acquired and congenital diseases) by echocardiographic results . 24.83% is the highest 
percentage of echocardiographic findings (paroxysmal atrial fibrillation) in patients that have No 
Structural Heart Disease. But, 94.6% is highest percentage of echocardiographic findings ( normal 
heart) among   control group. While, the Fallot tetralogy and Subacute infective endocarditis is less 
findings among  paroxysmal atrial fibrillation patients that represent 0.33% for both. But aortic 
aneurysm is less finding among  control people  that represent 0.33% . 
Table (4):  Association between echocardiographic findings in paroxysmal atrial 
fibrillation patients and in control people . 
 
Variables 
 
 
Echocardiographic 
findings of 
Patients with 
paroxysmal atrial 
fibrillation 
Echocardiographi
c of findings in 
control people 
P value 
Number (%) Number (%) 
*P value < 0.0001 1- Atrial septal aneurysm 
 
 
52(17.21%) 5(1.7%) 
2-Dilated left atrium 
 
37(12.25%) 0(0%) *P value < 0.0001 
3- Pericarditis  (pericardial  
effusion) 
 
11(3.64%) 0(0%) *P value < 0.0001 
4-Mitral valve prolapse and 
regurgitation 
 
 
35(11.58%) 10(3.3%) *P value < 0.0001 
5- No Structural Heart Disease  
 
 
75(24.83%) 284(94.6%)  
 
6-Subacute infective 
endocarditis 
 
1(0.33%) 0(0%) 
 
7-Cardiomyopathy (dilated 
cardiomyopathy ,hypertrophic 
cardiomyopathy) 
 
28(9.27%) 0(0%) 
 
8-Ischemic heart disease 
 
10(3.31%) 0(0%) 
 
9- Atrial septal defect 
 
3(0.99%) 0(0%) 
 
10-Fallot tetralogy (TOF) 
 
1(0.33%) 0(0%) 
 
11-Pulmonary hypertension 
 
8(2.64%) 0(0%) 
 
12-Aortic stenosis 
 
5(1.65%) 0(0%) 
 
13-Pulmonary embolism 
 
4(1.32%) 0(0%) 
 
14-Left ventricular hypertrophy 
(LVH) 
 
30(9.93%) 0(0%) 
 
15-Aortic aneurysm 2(0.66%) 1(0.33%)  
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*P value ≤0.05 is significant 
 
 
Discussion 
 
          Atrial septal aneurysm (ASA)  is defined as disused and movable interatrial septum tissue that 
is expanding at least10-15 mm during cardiac cycle [18] . It was associated with congenital heart 
disease (like atrial sepal defect ) and acquired heart disease, e.g. stroke and cardiac arrhythmias) [19]. 
 
 In the present study, the incidence of ASA is 8.6% , while the ASA incidence  reports   0.2%-4% 
using transthoracic echocardiography[20],and this study was done on young age [21] and middle age 
groups (Middle Age: definition of middle age in Oxford dictionary (American· English)  [22] 
 
        In our study, the paroxysmal atrial fibrillation patients are 34.44% and 65.56% for the age group 
20-40 old years and 41-55 old years respectively . The Rotterdam Study[23]  , the risk of lifetime of 
atrial fibrillation in age 55 years  was 22%- 24%, while in the Framingham cohort the risk of lifetime 
in age 40 years  was 23%- 26%. That indicates, there is increased   prevalence of atrial fibrillation 
with age[24]. 
 
      Also, we found that 82.78% and 17.22% of paroxysmal atrial fibrillation patients are present in 
male and female respectively . The atrial fibrillation incidence rate were 78/100,000 person per years 
and 60/100,000 person per years for males and females respectively[25]. This indicate that atrial 
fibrillation  is more in males than females.  
  
      We had found a significant relationship between paroxysmal atrial fibrillation and ASA (P value 
<0.05, odds ratio is 12.3, chi-square is 42.64 , 95% confidence interval 4.8-31.19) regarding both the 
sex and age  , it was currently showing that  atrial dysfunction, which is related to paroxysmal atrial 
fibrillation is commonly found in ASA patients in comparison to normal people, while the  atrial 
dysfunction mechanism is not clear [26].  
 
Conclusion  
ASA is very important structural cardiac abnormality that can be one of the leading 
causes of AF in middle and young age patients . 
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